STEK
Stemtech Corp
Key Financials
Net Income
$-4046705
↓ 7.4%
Revenue
$2.9M
↓ 43.1%
Gross Profit
$2.3M
↓ 38.0%
EPS (Diluted)
$-0.02
↑ 33.3%
Operating Income
$-2709047
↓ 13.5%
Total Liabilities
$10.6M
↑ 17.5%
Total Assets
$3.1M
↓ 16.7%
Cash & Equivalents
$132487.00
↓ 84.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 5/29/2026 | View on SEC |
| NT 10-Q/A | 5/14/2026 | View on SEC |
| NT 10-Q | 5/14/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 10-Q | 11/19/2025 | View on SEC |
| NT 10-Q | 11/14/2025 | View on SEC |
| 10-Q | 8/19/2025 | View on SEC |
| NT 10-Q | 8/14/2025 | View on SEC |
| 10-Q | 7/17/2025 | View on SEC |
| 10-K | 6/30/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | STEK |
| Company Name | Stemtech Corp |
| CIK | 1511820 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (954) 715-6000 |